|
2020
|
Invention
|
Antibodies to opgl.
Antibodies that interact with osteoprotegerin ligand (OPGL) are described. M... |
|
2019
|
Invention
|
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof.... |
|
|
Invention
|
Antibodies to m-csf.
The present invention relates to antibodies and antigen-binding portions th... |
|
|
Invention
|
Antibodies to madcam.
The present invention relates to antibodies including human antibodies and... |
|
2017
|
Invention
|
Antibodies to m-csf. The present invention relates to antibodies and antigen-binding portions the... |
|
|
Invention
|
Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses there... |
|
2016
|
Invention
|
Antibodies to madcam. The present invention relates to antibodies including human antibodies and ... |
|
|
Invention
|
Antibodies directed to gpnmb and uses thereof.
The present invention provides fully human monocl... |
|
2015
|
Invention
|
Antibodies to insulin-like growth factor i receptor.
The present invention relates to antibodies... |
|
|
Invention
|
Antibodies to cd40.
The present invention relates to antibodies and antigen-binding portions the... |
|
2014
|
Invention
|
Human monoclonal antibodies to ctla-4. In accordance with the present invention, there are provid... |
|
|
Invention
|
Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produce... |
|
|
Invention
|
Nucleic acids encoding antibodies to ccr2. Provided are antibodies including human antibodies and... |
|
2013
|
Invention
|
Antibodies to insulin-like growth factor i receptor. The present invention relates to antibodies ... |
|
|
Invention
|
Specific binding agents to hepatocyte growth factor.
Specific binding agents that interact with ... |
|
|
Invention
|
High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies... |
|
|
Invention
|
Treatment methods using c-met antibodies. The present invention relates to antibodies including h... |
|
|
Invention
|
Reducing the risk of human anti-human antibodies through v gene manipulation.
The present embodi... |
|
2012
|
Invention
|
Antibody categorization based on binding characteristics. Methods for categorizing antibodies bas... |
|
|
Invention
|
Antibodies that bind cd40 and methods of treating cancer and enhancing immune responses. The pres... |
|
|
Invention
|
Methods of monitoring a human anti-human antibody response and inhibitors thereof. The present em... |
|
|
Invention
|
Antibodies to c-met. The present invention relates to antibodies including human antibodies and a... |
|
|
Invention
|
Methods of treating cancer with human monoclonal antibodies to ctla-4. In accordance with the pre... |
|
|
Invention
|
Antibodies directed to gpnmb and uses thereof. The present invention provides fully human monoclo... |
|
2011
|
Invention
|
Human monoclonal antibodies to activin receptor-like kinase-1. The present invention relates to a... |
|
2010
|
Invention
|
Anti ige antibodies.
The present invention relates to novel human antibodies specifically direct... |
|
|
Invention
|
Antibodies to myostatin.
The present invention relates to antibodies including human antibodies ... |
|
|
Invention
|
Psma antibodies and uses thereof. The invention includes stable multimeric, particularly dimeric,... |
|
|
Invention
|
Nucleic acid molecules encoding antibodies to m-csf. The present invention relates to antibodies ... |
|
2009
|
Invention
|
Antibodies to ccr2. Provided are antibodies including human antibodies and antigen-binding portio... |
|
|
Invention
|
Antibodies against interleukin-1 β. Antibodies directed to the antigen IL-1β and uses of such ant... |
|
2008
|
Invention
|
Keel mechanism for sailboats. A keel (1) mechanism for a sailboat (10), wherein the keel (1) comp... |
